| ²é¿´: 967 | »Ø¸´: 1 | ||
withoutsunͳæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÎÄÏ×ͳ¼Æ·ÖÎö²¿·Ö£¬ÏëÇë½ÌÒ»ÏÂǰ±²ÃÇÕâÏîÑо¿µÄÑо¿ÈËȺÊýÁ¿ÊÇÔõôËã³öÀ´µÄ£¬Ð»Ð»£¡
|
|
¸ÃÑо¿·ÖÎöÁ˼¸Ç§È˵ÄÊý¾Ý¹¹½¨ÁËÒ»¸öÄ£ÐÍ£¬È»ºóÔÙ½øÐÐÄ£ÐÍÑéÖ¤¡£ÏÂÃæÊÇÑéÖ¤ÈËȺµÄÈë×éÊýÁ¿ÃèÊö£¬ÔÎÄÈçÏ£º The proportion of PN in the derivation cohort was 12.6%, and we assumed 25% as the point prevalence of individual risk factors, as in the Asia Pacific Colorectal Screening (APCS) study by Yeoh and colleagues. Based on these assumptions, a minimum of 3,100 subjects were needed to attain a power of >80% so that a risk factor with an odds ratio of two could be detected at a significance level of p < 0.05. Therefore, the other 3,789 subjects formed our validation cohort. Ö÷ÒªÊÇͳ¼Æ·½ÃæµÄÄÚÈÝ£¬ÒòΪÎұȽÏÍâÐУ¬ÏëÇë½Ìһϸ÷λǰ±²Õâ¸öÊÇÔõôËã³öÀ´µÄÄØ£¿Ð»Ð»£¡ |
» ²ÂÄãϲ»¶
²ÄÁϵ÷¼Á
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤
ÒѾÓÐ11È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ9È˻ظ´
±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085400µç×ÓÐÅÏ¢319Çóµ÷¼Á£¨½ÓÊÜ¿çרҵµ÷¼Á£©
ÒѾÓÐ5È˻ظ´
268Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
һ־Ը˫·Ç085502£¬267·Ö£¬¹ýËļ¶Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸085404£¬×Ü·Ö291£¬Ëļ¶Òѹý£¬Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
moonlupin
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 45.6
- Ìû×Ó: 12
- ÔÚÏß: 10·ÖÖÓ
- ³æºÅ: 671022
- ×¢²á: 2008-12-09
- ÐÔ±ð: MM
- רҵ: ÖÐҩѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
withoutsun: ½ð±Ò+2, ¡ïÓаïÖú, ºÃµÄлл£¬ÎÒÈ¥¿´¿´£¬µ«ÊǹؼüµÄÊDz»Ì«¶®Õâ¸öÑù±¾Á¿ÔõôËã³öÀ´µÄ 2020-04-01 21:14:40
withoutsun: ½ð±Ò+2, ¡ïÓаïÖú, ºÃµÄлл£¬ÎÒÈ¥¿´¿´£¬µ«ÊǹؼüµÄÊDz»Ì«¶®Õâ¸öÑù±¾Á¿ÔõôËã³öÀ´µÄ 2020-04-01 21:14:40
|
PNÔÚÑÜÉú¶ÓÁÐÖеİٷֱÈΪ12.6%£¬¶ø²Î¿¼Yeoh¼°ÆäͬÊÂÔÚÑÇÌ«µØÇø½á³¦Ö±³¦É¸²é£¨APCS£©Ñо¿ÖÐËù»ñµÃµÄ½á¹û£¬±¾Ñо¿ÖмÙÉè¸öÌåΣÏÕÒòËØµÄÖ²¡ÂÊΪ25%¡£»ùÓÚÕâЩ¼ÙÉ裬Ñо¿ÖÁÉÙÐèÒª3100ÃûÊÜÊÔÕß²ÅÄÜ»ñµÃ>80%µÄЧ¶È£¬ÒÔ±ãÔÚp <0.05µÄÏÔÖøÐÔˮƽÉÏÄܹ»¼ì²â³ö±ÈÖµ±ÈΪ2µÄ·çÏÕÒòËØ¡£Òò´Ë£¬ÆäËû3789ÃûÊÜÊÔÕß×é³ÉÁ˱¾Ñо¿µÄÑéÖ¤¶ÓÁС£ >80%µÄЧ¶È£¬Õâ¿é¶ùµÄ·Ò벻̫ȷ¶¨£¬Ò²¿ÉÒÔ·Òë³ÉЧÂÊ¡£ ½¨ÒéÂ¥Ö÷»¹µÃÈ¥¿´Ò»ÏÂAPCSÕâ¸öÑо¿£¬¸ãÇå³þËûµÄ½á¹û£¬Ò²¾ÍÊÇÄǸöÖ²¡ÂÊ25%ÔõôÀ´µÄ£¬ÕâÑù²ÅÄܸüºÃµØÀí½âÎÄÕ¡£ |
2Â¥2020-03-30 14:02:02














»Ø¸´´ËÂ¥